Therapeutic Cell Compositions and Methods of Manufacturing and Use Thereof

Create Medicines, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 62/946,896, filed Dec 11, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,980,836	Therapeutic Cell Compositions and Methods of Manufacturing and Use Thereof Create Medicines, Inc. In force Term ends Mar 23, 2040 · High confidence	Create Medicines, Inc.	In force	Term ends Mar 23, 2040	Term ends Mar 23, 2040	High confidence
US 12,252,545	Therapeutic Cell Compositions and Methods of Manufacturing and Use Thereof Create Medicines, Inc. In force Term ends Nov 2, 2040 · High confidence	Create Medicines, Inc.	In force	Term ends Nov 2, 2040	Term ends Nov 2, 2040	High confidence
Application 17/837,093	Therapeutic Cell Compositions and Methods of Manufacturing and Use Thereof Create Medicines, Inc. Pending Not granted	Create Medicines, Inc.	Pending	Not granted	not computed

3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

2 of these are in force and held by Create Medicines, Inc..

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.